383 related articles for article (PubMed ID: 19033926)
1. Immunohistochemical expression of survivin in cutaneous sebaceous lesions.
Calder KB; Khalil FK; Schlauder S; Cualing HD; Morgan MB
Am J Dermatopathol; 2008 Dec; 30(6):545-8. PubMed ID: 19033926
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
3. Expression of alpha-methylacyl-CoA racemase (P504S) in sebaceous neoplasms.
Halsey MA; Calder KB; Mathew R; Schlauder S; Morgan MB
J Cutan Pathol; 2010 Apr; 37(4):446-51. PubMed ID: 19638170
[TBL] [Abstract][Full Text] [Related]
4. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance?
Mulay K; Shah SJ; Aggarwal E; White VA; Honavar SG
Acta Ophthalmol; 2014 Dec; 92(8):e681-7. PubMed ID: 24930483
[TBL] [Abstract][Full Text] [Related]
5. Expression of oestrogen and progesterone receptors in canine sebaceous gland tumours.
Ginel PJ; Lucena R; Millán Y; González-Medina S; Guil S; García-Monterde J; de los Monteros AE; de las Mulas JM
Vet Dermatol; 2010 Jun; 21(3):297-302. PubMed ID: 20030798
[TBL] [Abstract][Full Text] [Related]
6. Abundant expression of neuronatin in normal eccrine, apocrine and sebaceous glands and their neoplasms.
Dugu L; Takahara M; Tsuji G; Iwashita Y; Liu X; Furue M
J Dermatol; 2010 Sep; 37(9):846-8. PubMed ID: 20883377
[No Abstract] [Full Text] [Related]
7. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland.
Liao Y; Zeng H; Wang X; Huang Y; Chen N; Ge B; Tang L; Luo Q
Exp Eye Res; 2009 Jan; 88(1):4-11. PubMed ID: 18955046
[TBL] [Abstract][Full Text] [Related]
8. Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas.
Heyl J; Mehregan D
J Cutan Pathol; 2008 Jan; 35(1):40-5. PubMed ID: 18095993
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin 15 expression in neoplasms with sebaceous differentiation.
Misago N; Narisawa Y
J Cutan Pathol; 2006 Sep; 33(9):634-41. PubMed ID: 16965339
[TBL] [Abstract][Full Text] [Related]
10. The role of survivin expression in the differential diagnosis of laryngeal (glottic) verrucous squamous cell carcinoma.
Marioni G; Pillon M; Bertolin A; Staffieri A; Marino F
Eur J Surg Oncol; 2007 Mar; 33(2):229-33. PubMed ID: 17088041
[TBL] [Abstract][Full Text] [Related]
11. Survivin products in pituitary tumors.
Jankowska A; Wasko R; Waligorska-Stachura J; Andrusiewicz M; Jaskula M; Liebert W; Sowinski J
Neuro Endocrinol Lett; 2008 Dec; 29(6):1033-7. PubMed ID: 19112393
[TBL] [Abstract][Full Text] [Related]
12. Loss of p21(WAF1) compartmentalisation in sebaceous carcinoma compared with sebaceous hyperplasia and sebaceous adenoma.
McBride SR; Leonard N; Reynolds NJ
J Clin Pathol; 2002 Oct; 55(10):763-6. PubMed ID: 12354803
[TBL] [Abstract][Full Text] [Related]
13. Expression of retinoid receptors in sebaceous cell carcinoma.
Chakravarti N; El-Naggar AK; Lotan R; Anderson J; Diwan AH; Saadati HG; Diba R; Prieto VG; Esmaeli B
J Cutan Pathol; 2006 Jan; 33(1):10-7. PubMed ID: 16441406
[TBL] [Abstract][Full Text] [Related]
14. An illustrative case of Muir-Torre syndrome: contribution of immunohistochemical analysis in identifying indicator sebaceous lesions.
Marazza G; Masouyé I; Taylor S; Prins C; Gaudin T; Saurat JH; French LE
Arch Dermatol; 2006 Aug; 142(8):1039-42. PubMed ID: 16924054
[TBL] [Abstract][Full Text] [Related]
15. Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome.
Harrington CR; Egbert BM; Swetter SM
Dermatol Surg; 2004 May; 30(5):817-9. PubMed ID: 15099333
[TBL] [Abstract][Full Text] [Related]
16. Nuclear survivin expression as a potentially useful tool for the diagnosis of canine cutaneous sebaceous lesions.
Bongiovanni L; Suter MM; Malatesta D; Ordinelli A; Ciccarelli A; Romanucci M; Brenner O; Della Salda L
Vet Dermatol; 2012 Oct; 23(5):394-e73. PubMed ID: 22681570
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous immunoreactivity of D2-40 antibody beyond the lymphatics.
Gomaa AH; Yaar M; Bhawan J
Am J Dermatopathol; 2007 Feb; 29(1):18-21. PubMed ID: 17284957
[TBL] [Abstract][Full Text] [Related]
18. Muir-torre syndrome with intriguing squamous lesions: a case report and review of the literature.
Nishizawa A; Nakanishi Y; Sasajima Y; Yamazaki N; Yamamoto A
Am J Dermatopathol; 2006 Feb; 28(1):56-9. PubMed ID: 16456327
[TBL] [Abstract][Full Text] [Related]
19. Comparative clinicopathological study of intraoral sebaceous hyperplasia and sebaceous adenoma.
Azevedo RS; Almeida OP; Netto JN; Miranda AM; Santos TC; Della Coletta R; Lopes MA; Pires FR
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):100-4. PubMed ID: 19101492
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry in ocular carcinomas.
Sramek B; Lisle A; Loy T
J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
